The US Food and Drug Administration (FDA) has approved Sanofi and Regeneron’s Dupixent (dupilumab) to treat adults and ...

Key steps for pharmaceutical companies to meet FDA’s upcoming nitrosamine testing requirements and ensure product safety.

BigHat Biosciences, a biotechnology company, has entered a strategic collaboration with Eli Lilly and Company.

Scale-up is a common problem encountered in all forms of development across industries, and oral solid dose manufacturing ...

Leveraging wearable and biometric technology to enhance compliance, boost efficiency, and improve workforce productivity in ...

How Ardena’s integrated services, nanomedicine expertise, and North American expansion are advancing drug development for ...

The future of aseptic small-batch manufacturing isn’t just about leading. Manufacturers who embrace automation, rethink ...

Incretin mimetics administered by auto-injectors or pens enable significant weight reduction and offer an important means of ...

Analytical laboratory testing plays a pivotal role in every stage of drug development and manufacturing. From route design and optimization to clinical trials and ultimately the finished product, ...

Thermo Fisher Scientific Inc. has opened its Advanced Therapies Collaboration Center (ATxCC) in Carlsbad, California.

Welcome to the April issue of Contract Pharma. This month’s edition highlights critical trends and challenges shaping the pharma manufacturing and development landscape, highlighting new regulatory ...

Rigaku and Spera Pharma have initiated a strategic partnership aimed at accelerating and transforming pharmaceutical development.